Skip to main content
Erschienen in: Intensive Care Medicine 7/2015

01.07.2015 | Letter

High-dose versus standard dose oseltamivir for treatment of severe influenza in adult intensive care unit patients

verfasst von: Sarah C. Welch, Simon W. Lam, Elizabeth A. Neuner, Seth R. Bauer, Stephanie N. Bass

Erschienen in: Intensive Care Medicine | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Prevention Centers for Disease Control and Prevention (2011) Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 60:1–25 Prevention Centers for Disease Control and Prevention (2011) Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 60:1–25
2.
Zurück zum Zitat Lee N, Hui DS, Zuo Z, Ngai KL, Lui GC et al (2013) A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections. Clin Infect Dis 57:1511–1519PubMedCrossRef Lee N, Hui DS, Zuo Z, Ngai KL, Lui GC et al (2013) A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections. Clin Infect Dis 57:1511–1519PubMedCrossRef
3.
Zurück zum Zitat South East Asia Infectious Disease Clinical Research Network (2013) Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial. BMJ 346:f3039PubMedCentralCrossRef South East Asia Infectious Disease Clinical Research Network (2013) Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial. BMJ 346:f3039PubMedCentralCrossRef
4.
Zurück zum Zitat Yen HL, Monto AS, Webster RG, Govorkova EA (2005) Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis 192:665–672PubMedCrossRef Yen HL, Monto AS, Webster RG, Govorkova EA (2005) Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis 192:665–672PubMedCrossRef
5.
Zurück zum Zitat Ariano RE, Sitar DS, Zelenitsky SA, Zarychanski R, Pisipati A et al (2010) Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. CMAJ 182:357–363PubMedCentralPubMedCrossRef Ariano RE, Sitar DS, Zelenitsky SA, Zarychanski R, Pisipati A et al (2010) Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. CMAJ 182:357–363PubMedCentralPubMedCrossRef
Metadaten
Titel
High-dose versus standard dose oseltamivir for treatment of severe influenza in adult intensive care unit patients
verfasst von
Sarah C. Welch
Simon W. Lam
Elizabeth A. Neuner
Seth R. Bauer
Stephanie N. Bass
Publikationsdatum
01.07.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 7/2015
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-015-3816-z

Weitere Artikel der Ausgabe 7/2015

Intensive Care Medicine 7/2015 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.